Cargando…

Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study

BACKGROUND: Despite the downward trend in the absolute number of tuberculosis (TB) cases since 2006 and the fall in the incidence rates since 2001, the burden of disease caused by TB remains a global health challenge. The co-infection between TB and HIV adds to this disease burden. TB is completely...

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Pamela, Peltzer, Karl, Louw, Julia, Matseke, Gladys, Mchunu, Gugu, Tutshana, Bomkazi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643857/
https://www.ncbi.nlm.nih.gov/pubmed/23622516
http://dx.doi.org/10.1186/1471-2458-13-396
_version_ 1782268384161824768
author Naidoo, Pamela
Peltzer, Karl
Louw, Julia
Matseke, Gladys
Mchunu, Gugu
Tutshana, Bomkazi
author_facet Naidoo, Pamela
Peltzer, Karl
Louw, Julia
Matseke, Gladys
Mchunu, Gugu
Tutshana, Bomkazi
author_sort Naidoo, Pamela
collection PubMed
description BACKGROUND: Despite the downward trend in the absolute number of tuberculosis (TB) cases since 2006 and the fall in the incidence rates since 2001, the burden of disease caused by TB remains a global health challenge. The co-infection between TB and HIV adds to this disease burden. TB is completely curable through the intake of a strict anti-TB drug treatment regimen which requires an extremely high and consistent level of adherence.The aim of this study was to investigate factors associated with adherence to anti-TB and HIV treatment drugs. METHODS: A cross-sectional survey method was used. Three study districts (14 primary health care facilities in each) were selected on the basis of the highest TB caseload per clinic. All new TB and new TB retreatment patients were consecutively screened within one month of anti-tuberculosis treatment. The sample comprised of 3107 TB patients who had been on treatment for at least three weeks and a sub-sample of the total sample were on both anti-TB treatment and anti-retro-viral therapy(ART) (N = 757). Data collection tools included: a Socio-Demographic Questionnaire; a Post-Traumatic-Stress-Disorder (PTSD) Screen; a Psychological Distress Scale; the Alcohol Use Disorder Identification Test (AUDIT); and self-report measures of tobacco use, perceived health status and adherence to anti-TB drugs and ART. RESULTS: The majority of the participants (N = 3107) were new TB cases with a 55.9% HIV co-infection rate in this adult male and female sample 18 years and older. Significant predictors of non-adherence common to both anti-TB drugs and to dual therapy (ART and anti-TB drugs) included poverty, having one or more co-morbid health condition, being a high risk for alcohol mis-use and a partner who is HIV positive. An additional predictor for non-adherence to anti-TB drugs was tobacco use. CONCLUSIONS: A comprehensive treatment programme addressing poverty, alcohol mis-use, tobacco use and psycho-social counseling is indicated for TB patients (with and without HIV). The treatment care package needs to involve not only the health sector but other relevant government sectors, such as social development.
format Online
Article
Text
id pubmed-3643857
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36438572013-05-04 Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study Naidoo, Pamela Peltzer, Karl Louw, Julia Matseke, Gladys Mchunu, Gugu Tutshana, Bomkazi BMC Public Health Research Article BACKGROUND: Despite the downward trend in the absolute number of tuberculosis (TB) cases since 2006 and the fall in the incidence rates since 2001, the burden of disease caused by TB remains a global health challenge. The co-infection between TB and HIV adds to this disease burden. TB is completely curable through the intake of a strict anti-TB drug treatment regimen which requires an extremely high and consistent level of adherence.The aim of this study was to investigate factors associated with adherence to anti-TB and HIV treatment drugs. METHODS: A cross-sectional survey method was used. Three study districts (14 primary health care facilities in each) were selected on the basis of the highest TB caseload per clinic. All new TB and new TB retreatment patients were consecutively screened within one month of anti-tuberculosis treatment. The sample comprised of 3107 TB patients who had been on treatment for at least three weeks and a sub-sample of the total sample were on both anti-TB treatment and anti-retro-viral therapy(ART) (N = 757). Data collection tools included: a Socio-Demographic Questionnaire; a Post-Traumatic-Stress-Disorder (PTSD) Screen; a Psychological Distress Scale; the Alcohol Use Disorder Identification Test (AUDIT); and self-report measures of tobacco use, perceived health status and adherence to anti-TB drugs and ART. RESULTS: The majority of the participants (N = 3107) were new TB cases with a 55.9% HIV co-infection rate in this adult male and female sample 18 years and older. Significant predictors of non-adherence common to both anti-TB drugs and to dual therapy (ART and anti-TB drugs) included poverty, having one or more co-morbid health condition, being a high risk for alcohol mis-use and a partner who is HIV positive. An additional predictor for non-adherence to anti-TB drugs was tobacco use. CONCLUSIONS: A comprehensive treatment programme addressing poverty, alcohol mis-use, tobacco use and psycho-social counseling is indicated for TB patients (with and without HIV). The treatment care package needs to involve not only the health sector but other relevant government sectors, such as social development. BioMed Central 2013-04-26 /pmc/articles/PMC3643857/ /pubmed/23622516 http://dx.doi.org/10.1186/1471-2458-13-396 Text en Copyright © 2013 Naidoo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Naidoo, Pamela
Peltzer, Karl
Louw, Julia
Matseke, Gladys
Mchunu, Gugu
Tutshana, Bomkazi
Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
title Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
title_full Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
title_fullStr Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
title_full_unstemmed Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
title_short Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study
title_sort predictors of tuberculosis (tb) and antiretroviral (arv) medication non-adherence in public primary care patients in south africa: a cross sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643857/
https://www.ncbi.nlm.nih.gov/pubmed/23622516
http://dx.doi.org/10.1186/1471-2458-13-396
work_keys_str_mv AT naidoopamela predictorsoftuberculosistbandantiretroviralarvmedicationnonadherenceinpublicprimarycarepatientsinsouthafricaacrosssectionalstudy
AT peltzerkarl predictorsoftuberculosistbandantiretroviralarvmedicationnonadherenceinpublicprimarycarepatientsinsouthafricaacrosssectionalstudy
AT louwjulia predictorsoftuberculosistbandantiretroviralarvmedicationnonadherenceinpublicprimarycarepatientsinsouthafricaacrosssectionalstudy
AT matsekegladys predictorsoftuberculosistbandantiretroviralarvmedicationnonadherenceinpublicprimarycarepatientsinsouthafricaacrosssectionalstudy
AT mchunugugu predictorsoftuberculosistbandantiretroviralarvmedicationnonadherenceinpublicprimarycarepatientsinsouthafricaacrosssectionalstudy
AT tutshanabomkazi predictorsoftuberculosistbandantiretroviralarvmedicationnonadherenceinpublicprimarycarepatientsinsouthafricaacrosssectionalstudy